Related Experiment Video
Updated: Aug 22, 2025

08:52
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
8.9K
Hazardous giant pharyngoesophageal liposarcoma
Subagar Anbarasan1, Suresh Mani2, Gaurav Goel1
1Department of ENT - Head and Neck Surgery, All India Institute of Medical Sciences, New Delhi, India.
BMJ Case Reports
|November 10, 2022
Summary
An elderly man experienced worsening dysphagia and breathing difficulty due to a pharyngeal mass. Initially diagnosed as a benign polyp, it was surgically removed and revealed to be a rare liposarcoma, highlighting advanced diagnostic and surgical techniques.
Area of Science:
- Otorhinolaryngology
- Surgical Pathology
- Oncology
Background:
- Pharyngeal masses can cause significant dysphagia and airway compromise.
- Fibrovascular polyps are typically benign, but malignant transformation or misdiagnosis can occur.
- Early and accurate diagnosis is crucial for effective management of pharyngeal lesions.
Observation:
- An elderly male presented with progressive dysphagia and acute respiratory distress.
- Endoscopic examination revealed an elongated, fatty mass with a stalk on the posterior pharyngeal wall.
- Initial clinical and radiological assessments suggested a benign fibrovascular polyp.
Findings:
- Transoral endoscopic resection using a vessel sealing device was performed.
- Histopathological examination confirmed the mass as a well-differentiated liposarcoma.
- The patient achieved a full recovery after surgical excision.
Implications:
- This case underscores the importance of histopathological confirmation for pharyngeal masses, even with apparent benign features.
- Advanced endoscopic techniques and technologies facilitate minimally invasive resection of complex pharyngeal lesions.
- Integrated preoperative assessment, surgical technology, and targeted therapy are vital for managing challenging pharyngoesophageal polyps.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
5.3K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.3K
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Barrett Esophagus-I: Introduction
154
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
154

